Drug Resistance in Cancer

Drug resistance to cancer treatments is a major concern for patients with the disease. Single and multi-drug resistance to cancer therapeutics can occur, making it difficult to kill the cancer cells. Here is the latest research on drug resistance in cancer.

August 14, 2020
Review

Hydroxamic acid hybrids as the potential anticancer agents: An Overview

European Journal of Medicinal Chemistry
Wenhua LiuXiaoyong Si
August 14, 2020
Review
Open Access

Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Ka Hong WongZhijun Yang
August 13, 2020
Review
Open Access

Implications of lipid droplets in lung cancer: Associations with drug resistance

Oncology Letters
Chunlai Jin, Peng Yuan
August 12, 2020

Exosomes in head and neck cancer: Roles, mechanisms and applications

Cancer Letters
Jun CaoFangfang Zhou
August 14, 2020

Analytical Challenges in Development of Chemoresistance Predictors for Precision Oncology

Analytical Chemistry
Mariana Bleker de OliveiraSergey N Krylov
August 13, 2020
Open Access

Targeting CDK4/6 in mantle cell lymphoma

Annals of Lymphoma
Christina LeeSelina Chen-Kiang
August 14, 2020
Open Access

Multiomics reveals ectopic ATP synthase blockade induces cancer cell death via a lncRNA-mediated phospho-signaling network

Molecular & Cellular Proteomics : MCP
Yi-Wen ChangHsueh-Fen Juan
August 14, 2020

Stress Granules in Cancer

Reviews of Physiology, Biochemistry and Pharmacology
Min-Seok Song, Elda Grabocka

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2020 Meta ULC. All rights reserved
/feed-previews/drug-resistance-in-cancer/82f7f52e-abb0-4841-85db-8c8a8e28c0c7